Ascot, UK (PRWEB) January 3, 2006
Baxa Ltd announces its move to direct sales and marketing operations in France, Belgium, The Netherlands and Luxembourg beginning January 1st 2006. In the ten years previous, Baxa products were sold primarily through exclusive distributors in these countries, with customer and technical support provided by Baxa Ltd from their European Headquarters in Ascot, Berkshire.
“These changes present us with huge opportunities to build on the successes of our Distributor partners and improve both our service and our products through a closer understanding of customer needs,’ says Terry Aston, Managing Director, Baxa Ltd.
The move to a direct sales model promotes the company’s strategy of fostering close customer relationships and strengthens Baxa Ltd’s presence in these countries. Baxa currently has direct sales operations in the United Kingdom, Denmark and Germany, and supports distribution partners in 16 other countries in Europe, the Middle East and Africa. Product distribution across mainland Europe will be handled via a European warehouse hub in Gent in Belgium, where customer orders will be processed and shipped.
“We are working closely with our Distributors to ensure the transition will be seamless from a customer perspective,” states Brendan Parker, Baxa Ltd Sales and Marketing Director. “We look forward to continuing the excellent customer support previously provided by our Distributors.”
Baxa Ltd provides systems and products that streamline pharmacy operations for oral liquid delivery, sterile IV preparation and mixing multi-source parenteral solutions. The company’s products provide solutions for enhancing patient safety, improving drug preparation procedures and reducing the opportunity for medication errors. The UK operation is a subsidiary of Baxa Corporation, based in Colorado.
About Baxa Corporation
Celebrating 30 years of business in 2005, Baxa Corporation is a Denver-based manufacturer of medical devices and systems for preparing, handling, packaging, and administering liquid medications. The company manufactures and markets a wide range of healthcare products for use in hospitals, critical care units and alternate-site pharmacies. Privately held, Baxa Corporation has subsidiaries in Canada, the United Kingdom, sales infrastructure in Germany and Denmark, and distribution partners worldwide. Further information is available at http://www.baxa.com.
Baxa Ltd: Tel +44 (0)1344 890916
Maggie Chamberlin Holben, APR
Absolutely Public Relations: 303.984.9801 or 303.669.3558
# # #